Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp C Rommel

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53αChristopher Roselle, Izumi Horikawa, Linhui Chen, et al.
The Journal of Experimental Medicine|December 21, 2012
Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switchingAnne Bothmer, Philipp C Rommel, Anna Gazumyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Cell|June 25, 2026
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapyDaniel J Baker, Leon M Frommer, Ugur Uslu, et al.
Nature|June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53αChristopher Roselle, Izumi Horikawa, Linhui Chen, et al.
The Journal of Experimental Medicine|December 21, 2012
Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switchingAnne Bothmer, Philipp C Rommel, Anna Gazumyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Cell|June 25, 2026
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapyDaniel J Baker, Leon M Frommer, Ugur Uslu, et al.
Nature|June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Pageof 2